To test this hypothesis, we assessed Cx26 mRNA expression across multiple breast cancer subtypes using the breast cancer gene expression miner (version 4.0; http://bcgenex.centregauducheau.fr/). The gene discussed is GJB2; the disease is breast carcinoma.